- Arizona’s Bioscience Roadmap
Building Arizona as a global center for research and commercialization in the biosciences and a leader in such areas as precision medicine.
The Flinn Foundation supports the biosciences in Arizona through research grants and stewardship of Arizona’s Bioscience Roadmap, released in 2002 and guiding the growth and development of the state’s bioscience sector through 2025.
The Roadmap’s tagline, “Advancing the Biosciences and Improving Health Outcomes” recognizes the broad spectrum of the biosciences, including research, academia, and product commercialization, as well as the central role of health care within the bioscience sector.
Responding to the COVID-19 pandemic, the Phoenix-based Flinn Foundation has issued an emergency $100,000 grant to the Translational Genomics Research Institute (TGen) to support population-based testing of the novel coronavirus in Arizona and to help TGen immediately and dramatically ramp up its capacity to analyze individual samples for the disease. The initiative is also being funded with grants from the Phoenix-based Virginia G. Piper Charitable Trust and the Flagstaff-based NARBHA Institute. TGen North, the nonprofit institute’s pathogen-genomics division, is based in Flagstaff.
Another project supported by a previous Flinn Foundation grant, the Prevent HAARM initiative, is contributing to Arizona’s response to COVID-19. Led by the Tucson-based Critical Path Institute with TGen North playing a major role, Prevent HAARM focuses on deploying tools for surveillance of hospital-acquired infections; applications to the current pandemic are being developed. [Read more]
Six bioscience companies creating innovative solutions to improve regenerative medicine, spinal surgery, sleep health, medical payments, the food supply, and even ear cleaning have been selected for the 2020 Flinn Foundation Bioscience Entrepreneurship Program.
The Arizona-based firms will each receive $30,000 in funding support through a nonprofit partner, a personalized plan to help advance the company, and connections with the state’s bioscience and policy leaders.
Dr. Sarah Coles was one of the first 24 medical students admitted to the University of Arizona College of Medicine-Phoenix.
And her commitment to the city’s first medical school has never gone away.
Coles, a Flinn-Brown Fellow, is a physician, educator, curriculum developer, policy expert, a member of state and national boards, and overall advocate for patient health.
Her career today is based one mile south of North High School in central Phoenix, where Coles was selected as a Flinn Scholar in 2002 and chose to attend the University of Arizona—sparking a lifelong commitment to the health of the state. [Read more]
Arizona’s leading research institutions—universities, independent institutes, and research hospitals—are collaborating on bioscience projects to advance health care through a Flinn Foundation grants program designed to translate innovations and discoveries into patient care more quickly.
The eight grants, valued at $100,000 each, will fund research between basic and clinical researchers at Arizona’s three public universities, HonorHealth Research Institute, St. Joseph’s Hospital and Medical Center and Barrow Neurological Institute, and the Translational Genomics Research Institute, as well as external partners that range from Mayo Clinic Arizona to Microsoft to Los Alamos National Laboratory. [Read more]
The Technology and Research Initiative Fund, approved by Arizona voters nearly 20 years ago, has enabled Arizona’s three public universities to build new cutting-edge research facilities and attract world-renowned scientists to the state, increase research grants and other external funding, commercialize new technology and launch startups, and provide research opportunities for college students.
Since its inception as part of Proposition 301, TRIF has raised more than $1 billion for Arizona State University, Northern Arizona University, and the University of Arizona. [Read more]
Stay up to date. Join our email list.
Arizona hospitals, universities, research institutes and private labs are working to increase COVID-19 testing, including Arizona State University’s Biodesign Institute which received a $2 million grant from the Virginia G. Piper Charitable Trust. Hospitals continue preparations for additional cases, while researchers and startups are developing products to help in the fight against the coronavirus as […]
Listen to an interview with David Engelthaler of TGen North, which developed a COVID-19 test and is tracking the disease’s origin and spread through genetic research, and Josh LaBaer of Arizona State University’s Biodesign Institute. And learn more about new test kits being assembled at the University of Arizona, drive-through testing sites, and how businesses, […]
Arizona bioscience institutions and hospitals are expanding coronavirus testing, including using robots to accelerate the tests, while the number of cases in the state continues to rise. Learn more about the work of researchers, physicians and others on the front line in addition to the emergency measures being taken by our hospitals, nursing homes, schools […]
Conference center closes, staff to work from home Responding to the COVID-19 pandemic, the Phoenix-based Flinn Foundation has issued an emergency $100,000 grant to the Translational Genomics Research Institute (TGen) to support population-based testing of the novel coronavirus in Arizona and to help TGen immediately and dramatically ramp up its capacity to analyze individual samples for the disease. Meanwhile, following guidance from the U.S. Centers for Disease […]